Skip to content
← Back to this collection

PUBLICATIONS · 31160249

Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2019 Jul
First author
Judson I

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2019 Jul;20(7):901-903. doi: 10.1016/S1470-2045(19)30324-9.
    note
    Source null
    related pmid
    31160250
    relationship
    Comment in

Authors and identifiers

  1. name
    Judson I
    type
    Author
  2. name
    Morden JP
    type
    Author
  3. name
    Kilburn L
    type
    Author
  4. name
    Leahy M
    type
    Author
  5. name
    Benson C
    type
    Author
  6. name
    Bhadri V
    type
    Author
  7. name
    Campbell-Hewson Q
    type
    Author
  8. name
    Cubedo R
    type
    Author
  9. name
    Dangoor A
    type
    Author
  10. name
    Fox L
    type
    Author
  11. name
    Hennig I
    type
    Author
  12. name
    Jarman K
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Judson I
    type
    Author
  2. name
    Morden JP
    type
    Author
  3. name
    Kilburn L
    type
    Author
  4. name
    Leahy M
    type
    Author
  5. name
    Benson C
    type
    Author
  6. name
    Bhadri V
    type
    Author
  7. name
    Campbell-Hewson Q
    type
    Author
  8. name
    Cubedo R
    type
    Author
  9. name
    Dangoor A
    type
    Author
  10. name
    Fox L
    type
    Author
  11. name
    Hennig I
    type
    Author
  12. name
    Jarman K
    type
    Author
bibliography ids
  1. nci-bib-806f9331eeeb098213d5b462
book metadata
content sha256
721d2653d8a86ce8086855fb7facb44931a4b509b7657ac6156adbe3d8da4706
document type
citation
dois
  1. 10.1016/S1470-2045(19)30215-3
electronic publication date
display
2019 May 31
precision
day
year
2019
evidence scope
bibliographic_metadata_only
id
pubmed:31160249
immutable id
pubmed:31160249@721d2653d8a86ce8086855fb7facb44931a4b509b7657ac6156adbe3d8da4706
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
7
name
The Lancet. Oncology
nlm unique id
100957246
pages
1023-1034
volume
20
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2019 Jul;20(7):901-903. doi: 10.1016/S1470-2045(19)30324-9.
    note
    Source null
    related pmid
    31160250
    relationship
    Comment in
outcomes validated
false
pmid
31160249
provenance
batch id
23ffe1e2a9e160b6dca0
provider
NCBI PubMed ESummary
record sha256
f198c76869ddb29dc91f1200f40a55f1f25d8c8d2fe97c693d72cd87bb6079b9
response sha256
d5cbfde8f87ba85b214c53aaf0e8fa33d70fec48dd4fde7745538180cd7e1841
retrieved at
2026-09-09T23:47:44.690737+00:00
publication date
display
2019 Jul
precision
month
year
2019
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Randomized Controlled Trial
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/31160249/
title
Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial.

Preserved source evidence · Not medical advice